Investigation of the effect of Masport on Excessive Underarm Sweating

Phase 3

Completed

• Conditions: Primary Axillary Hyperhydrosis.; Primary focal hyperhidrosis, axilla; L74.510

• Registration Number: IRCT20220620055230N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-11-21

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Adults aged between 18 to 65 years who have a sweating rate of 50 mg per minute or higher.

Exclusion Criteria

secondary Hyperhidrosis due to systemic problems.
Pregnancy
Lactation
people who have taken Aminoglycosides in the last three weeks.
people who have had botulinum toxin injection in the past year.
people with Neuromuscellar diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The score of sweating rate in the questionnaire of Hyperhidrosis disease severity scale by patients. Timepoint: scoring of the amount of sweating will be done on day 0 (before the stat of the study), 14, 90 and 180 days after botulinum toxin injection. Method of measurement: The questionnaire Hyperhidrosis disease severity scale.;Sweating rate based on Gravimetry test. Timepoint: measurement of the sweating will be done on day 0 (before the stat of the study), 14, 90 and 180 days after botulinum toxin injection. Method of measurement: Using a digital scale.;Occurrence of the side effects, The time of onset and duration of the complication. Timepoint: Patients will be able to report occurrence of the side effects throughout the study, but they will be asked specifically on 14th, 90th and 180th after Botulinum Toxin injection. Method of measurement: Statements of patients.